Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Growth and Bone Abnormalities in Noonan Syndrome
NCT02713945Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jan 2017
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simvastatin in Noonan syndrome, sponsored by Centre hospitalier universitaire de Toulouse. Started Jan 2017; status: completed.
02
Drugs
simvastatin
03
Conditions
Noonan syndrome
Beyond the preview
Go deeper on NCT02713945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02713945.